CBCallee Brooks
Callee Brooks
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Callee Brooks has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Kathryn Kennedy
Vanderbilt University Medical Center
2 shared publications - Sarah Profitt
Vanderbilt University Medical Center
2 shared publications - Adetola Kassim
Department of Medicine, Division of Hematology/Oncology, Vanderbilt-Meharry Center for Excellence in Sickle Cell Disease, Vanderbilt University Medical Center, Nashville, TN, USA
1 shared publication - Ashwin Kishtagari
Vanderbilt University Medical Center, Division of Hematology/Oncology
1 shared publication - Bhagirathbhai Dholaria
Vanderbilt University Medical Center, Nashville, TN
1 shared publication - Bipin N. Savani
Vanderbilt University Medical Center, Nashville, TN, USA
1 shared publication
Latest Publications
- Open Access
- 2 October 2026
- Published by Binaytara in International Journal of Cancer Care and Delivery
- Vol. 6 (Supplement) , 1-2
Healthcare Resource Utilization and Cost Implications of Outpatient Bispecific Antibody Step-Up Dosing in Relapsed/Refractory Multiple Myeloma: A Real-World Experience from a Large Academic Center
From the 2026 National Summit on Hematologic Cancers
- 2 October 2026
- Published by Binaytara in International Journal of Cancer Care and Delivery
- Vol. 6 (Supplement) , 1-2
Open AccessHealthcare Resource Utilization and Cost Implications of Outpatient Bispecific Antibody Step-Up Dosing in Relapsed/Refractory Multiple Myeloma: A Real-World Experience from a Large Academic Center
From the 2026 National Summit on Hematologic Cancers
- Open Access
- 25 September 2026
- Published by Binaytara in International Journal of Cancer Care and Delivery
- Vol. 6 (Supplement) , 1-2
Context-Dependent Prognostic Significance of RAS Mutations in AML and Implications for Treatment Strategy
From the 2026 National Summit on Hematologic Cancers
- 25 September 2026
- Published by Binaytara in International Journal of Cancer Care and Delivery
- Vol. 6 (Supplement) , 1-2
Open AccessContext-Dependent Prognostic Significance of RAS Mutations in AML and Implications for Treatment Strategy
From the 2026 National Summit on Hematologic Cancers